Results about: innovation
The company concludes a 2.2 million € round led by ”la Caixa” through Caixa Capital Risc. Also participating in the operation were Ysios Capital and Fundación Vila Casas.
Inbiomotion, a spin off founded by IRB Barcelona's group leader, Roger Gomis, develops diagnostic products for predicting risks that cancer patients may suffer bone metastasis.
The goal is to speed up the transfer of technologies developed in the six BIST research institutes to the marketplace.
A study published today in the Journal of National Cancer Institute (JNCI) by ICREA researcher Roger Gomis may be key to the early detection of patients at risk of developing metastasis to the bone
This new knowledge may accelerate the development of the first preventive treatment of bone metastasis
Inbiomotion, an IRB Barcelona spin off company and financed with venture investors Ysios Capital, has already begun clinical trials